CD80 and neoplasm: In summary, we discovered that the ligation of PD-L1 on tumour cells by circulating PD-1/CD80+ I-sEVs resulted in an intense and adaptive immunologically ‘cold’ tumour phenotype (Supplementary Fig. 10).